http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c3515f1be18f66f4e1a05c287ba70090
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Steven Leeder Leeder |
| name | J. Steven Leeder J Steven Leeder |
| given-name | J. Steven J Steven J. J |
| organization-name | Children’s Mercy Kansas City Kansas City Missouri USA; University of Missouri‐Kansas City School of Medicine Kansas City Missouri USA; University of Kansas Medical Center Kansas City Kansas USA Division of Clinical Pharmacology & Therapeutic Innovation, Children‘s Mercy Hospital & Clinics & Department of Pediatrics, University of Missouri-Kansas City, 2401 Gillham Road, Kansas City, MO 64108, USA Department of Pediatrics Children’s Mercy Kansas City Kansas City Missouri USA Division of Clinical Pharmacology, Medical Toxicology and Therapeutic Innovation Children's Mercy Kansas City Missouri USA; Department of Pediatrics University of Missouri‐Kansas City School of Medicine Kansas City Missouri USA Clinical Pharmacology Chief, Division of Clinical Pharmacology and Medical Toxicology; Professor of Pediatrics and Pharmacology, Children's Mercy Hospitals and Clinics, Kansas City, MO Division of Clinical Pharmacology and Medical Toxicology Children's Mercy Hospitals and Clinics Kansas City Missouri Bioinformatics and Intelligent Computing, Division of Clinical Pharmacology and Toxicology, Children’s Mercy Hospitals and Clinics, 2401 Gillham Road, Kansas City, Missouri 64108, and School of Medicine, University of Missouri−Kansas City, Kansas City, Missouri 64110 Marion Merrell Dow/Missouri Endowed Chair in Pediatric Clinical Pharmacology, Director, Division of Clinical Pharmacology Toxicology and Therapeutic Innovation, Children's Mercy Kansas City, Professor of Pediatrics and Pharmacology, Schools of Medicine and Pharmacy, University of Missouri‐Kansas City Missouri USA Department of Clinical Pharmacology Children's Mercy Hospital Kansas City MO USA Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation Department of Pediatrics Children's Mercy Kansas City Kansas City Missouri USA; School of Medicine University of Missouri‐Kansas City Kansas City Missouri USA Division of Clinical Pharmacology & Therapeutic Innovation, The Children’s Mercy Hospital & Clinics, 2401 Gillham Road, Kansas City, MO 64108, USA Children’s Mercy Hospitals & Clinics, Division of Clinical Pharmacology, 2401 Gillham Road, Kansas City, MO 64110, USA Division of Pediatric Clinical Pharmacology and Medical Toxicology, Children’s Mercy Hospital and Clinics, Kansas City, Missouri; and Division of Pediatric Clinical Pharmacology and Medical Toxicology, Children's Mercy Hospital and Clinics Kansas City MO; Departments of Psychiatry and Medicine, Morehouse School of Medicine Atlanta Ga. Division of Clinical Pharmacology, Toxicology, & Therapeutic Innovation Children's Mercy Kansas City Kansas City Missouri USA Department of Paediatrics University of Missouri Kansas City MO USA; Divisions of Paediatric Pharmacology and Medical Toxicology Children's Mercy Hospitals and Clinics Kansas City MO USA Section of Developmental Pharmacology & Experimental Therapeutics, The Children’s Mercy Hospital and Clinics, 2401 Gillham Road, Kansas City, 62108 MO, USA. Division of Clinical Pharmacology Toxicology and Therapeutic Innovation, Children's Mercy Hospital Kansas City Missouri USA Department of Pediatrics, University of Missouri-Kansas City; Department of Pharmacology, University of Missouri-Kansas City, The Children's Mercy Hospital, Kansas City, Missouri; Section of Pediatric Clinical Pharmacology and Experimental Therapeutics, The Children's Mercy Hospital, Kansas City, Missouri Division of Clinical Pharmacology Medical Toxicology and Therapeutic Innovation Children's Mercy Kansas City MO USA; Department of Pediatrics University of Missouri‐Kansas City School of Medicine Kansas City MO USA Division of Pediatric Pharmacology & Medical Toxicology, The Children’s Mercy Hospital & Clinics, 2401 Gillham Rd, Kansas City, MO 64108, USA Department of Pediatrics; University of Missouri-Kansas City School of Medicine; Kansas City MO USA; Department of Pharmacology; University of Missouri-Kansas City School of Pharmacy; Kansas City MO USA; Divisions of Clinical Pharmacology, Toxicology, and Therapeutic Innovation; Children's Mercy Hospitals and Clinics; Kansas City MO USA Children's Mercy Hospital Kansas City Missouri USA Division of Developmental Pharmacology and Medical Toxicology, The Children’s Mercy Hospital and Clinics, Kansas City, MO 64108 Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Department of Pediatrics, Children’s Mercy Kansas City & University of Missouri-Kansas City, 2401 Gillham Rd, Kansas City, MO 64108, USA Division of Clinical Pharmacology, Toxicology, & Therapeutic Innovation Department of Pediatrics Children's Mercy Kansas City Kansas City Missouri USA Section of Developmental Pharmacology and Experimental Therapeutics, The Children's Mercy Hospital and Clinics, Kansas City, MO, USA Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Department of Pediatrics Children's Mercy‐Kansas City Kansas City Missouri USA; School of Medicine University of Missouri‐Kansas City Kansas City Missouri USA Division of Clinical Pharmacology and Therapeutic Innovation, Children’s Mercy Hospitals and Clinics, and ‡Department of Pediatrics, School of Medicine, University of Missouri Kansas City, 2401 Gillham Road, Kansas City, Missouri 64108, United States Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation Children’s Mercy Kansas City Missouri USA; Department of Pediatrics University of Missouri‐Kansas City School of Medicine Kansas City Missouri USA Department of Pediatrics, Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Hospital, University of Missouri Kansas City School of Medicine, Kansas City, MO 64152, USA Children’s Mercy Kansas City Kansas City Missouri USA; University of Missouri Kansas City School of Medicine Kansas City Missouri USA; University of Kansas School of Medicine Kansas City Kansas USA Clinical Pharmacology Research Center and Department of Medicine, Bassett Healthcare, Cooperstown;Division of Pediatric Pharmacology and Medical Toxicology, Children's Mercy Hospitals and Clinics, Kansas City;Departments of Pediatrics and Pharmacology, University of Missouri‐Kansas City, Kansas City;University of Toronto, Toronto;University of North Carolina School of Pharmacy, Chapel Hill, NC, USA Section of Developmental Pharmacology and Experimental Therapeutics, Division of Pediatric Pharmacology and Medical Toxicology, Children’s Mercy Hospital and Clinics, Kansas City, MO, USA. sleder@cmh.edu Division of Developmental Pharmacology and Medical Toxicology, The Children's Mercy Hospital and Clinics, Kansas City, Mo, USA Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Children's Mercy Hospital Kansas City Missouri USA Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation, Department of Pediatrics, Children's Mercy Kansas City and University of Missouri-Kansas City, Kansas City, MO, USA. sleeder@cmh.edu. Division of Clinical Pharmacology & Medical Toxicology, Children’s Mercy Hospitals & Clinics & University of Missouri – Kansas City, Kansas City, MO, USA; Department of Pediatrics, Children’s Mercy Hospitals & Clinics & University of Missouri – Kansas City, Kansas City, MO, USA Clinical Pharmacology & Medical Toxicology, Children’s Mercy Hospitals & Clinics, Kansas City, MO, USA Children's Mercy Hospital and Clinics, Kansas City, Missouri Division of Pediatric Clinical Pharmacology and Medical Toxicology, Children's Mercy Hospitals and Clinics; Departments of Pediatrics, Pharmacology, and Pharmacy Practice University of Missouri‐Kansas City Kansas City; Clinical Pharmacology Research Center and Department of Medicine, Bassett Healthcare Cooperstown; Division of Pharmacy Practice University of North Carolina Chapel Hill; Department of Pharmaceutical Sciences St Jude's Children's Hospital Memphis Children's Mercy Research Institute, Children's Mercy Kansas City, Kansas City, MO Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation Children’s Mercy Kansas City Kanas City Missouri USA; School of Medicine University of Missouri‐Kansas City Kansas City Missouri USA Children's Mercy Kansas City Kansas City Missouri Department of Pharmacology and Therapeutics, The University of Liverpool, Liverpool, United Kingdom, Department of Pediatrics and Pharmacology, University of Missouri-Kansas City, Kansas City, Missouri, and Faculty of Pharmacy, University of Toronto, 19 Russell Street, Toronto, Canada, M5S 2S2 Division of Clinical Pharmacology and Medical Toxicology, Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy‐Kansas City, Missouri, and School of Medicine University of Missouri‐Kansas City Kansas City Missouri USA Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation Children's Mercy Kansas City MO USA; Department of Pediatrics University of Missouri‐Kansas City School of Medicine MO USA Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Department of Pediatrics Children's Mercy‐Kansas City Kansas City MO USA; School of Medicine University of Missouri‐Kansas City Kansas City MO USA Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Hospitals & Clinics, Kansas City, MO, USA; Department of Pediatrics, University of Missouri-Kansas City, Kansas City, MO, USA Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation Department of Pediatrics, Children's Mercy Kansas City University of Missouri‐Kansas City Kansas City Missouri USA Division of Clinical Pharmacology & Medical Toxicology, Children’s Mercy Hospitals & Clinics, 2401 Gillham Road, Kansas City, MO 64108, USA Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, and School of Medicine University of Missouri‐Kansas City Kansas City Missouri USA Division of Clinical Pharmacology and Medical Toxicology Children's Mercy Hospitals and Clinics 2401 Gillham Road Kansas City MO 64108 USA Department of Pediatrics University of Missouri Kansas City School of Medicine Kansas City Missouri USA; Division of Clinical Pharmacology Toxicology and Therapeutic Innovation, Children's Mercy Hospital Kansas City Missouri USA Children’s Mercy Hospital/University of Missouri at Kansas City, Kansas City, MO, USA Clinical Pharmacology Research Center, Department of Medicine, Department of Pharmacy Services, Bassett Healthcare, Cooperstown, NY;The Division of Pediatric Clinical Pharmacology and Experimental Therapeutics, Children's Mercy Hospital and Clinics, and the Departments of Pediatrics and Pharmacology, University of Missouri–Kansas City, Kansas City, Mo |
Incoming Links
Total number of triples: 249.